Ισραήλ - Εβραϊκά - Ministry of Health

vitamed pharmaceutical industries ltd - cetrimide - שמפו - cetrimide 10 % - cetrimide - cetrimide - for the treatment of dandruff.

Ισραήλ - Εβραϊκά - Ministry of Health

megapharm ltd - pimecrolimus - קרם - pimecrolimus 1 % - pimecrolimus - pimecrolimus - elidel 1 % cream is indicated for the short-term treatment of the signs and symptoms of atopic dermatitis (eczema) and intermittent long-term treatment to prevent progression to flares in patients 3 months of age and above. treatment with elidel is indicated in patients in whom the use of conventional topical corticosteroids therapy is deemed inadvisable because of potential risks or in patients who are not adequately responsive to or intolerant of conventional topical corticosteroids therapy.

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 30 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective.endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 20 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 10 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.

Ισραήλ - Εβραϊκά - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - אבקה להכנת תרחיף - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - augmentin es is indicated for the treatment of acute otitis media in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant streptococcus pneumoniae:consideration should be given to official guidance on the appropriate use of antibacterial agents.

Ισραήλ - Εβραϊκά - Ministry of Health

merck sharp & dohme israel ltd - caspofungin as acetate - אבקה להכנת תמיסה מרוכזת לעירוי - caspofungin as acetate 50 mg/vial - caspofungin - caspofungin - cancidas is indicated in adults and pediatric patients (3 months and older) for:- empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. cancidas has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). cancidas has not been studied as initial therapy for invasive aspergillosis.

Ισραήλ - Εβραϊκά - Ministry of Health

merck sharp & dohme israel ltd - caspofungin as acetate - אבקה להכנת תמיסה מרוכזת לעירוי - caspofungin as acetate 70 mg/vial - caspofungin - caspofungin - cancidas is indicated in adults and pediatric patients (3 months and older) for:- empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. cancidas has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). cancidas has not been studied as initial therapy for invasive aspergillosis.

Ισραήλ - Εβραϊκά - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - תרחיף - aciclovir 200 mg / 5 ml - aciclovir - aciclovir - zovirax oral presentations are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes, for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients, for the prophylaxis of herpes simplex infections in immune-compromised patients and for the treatment of herpes zoster (shingles) infections. studies have shown that early treatment of shingles with zovirax has a beneficial effect on pain and can reduce the incidence of post-herpetic neuralgia (zoster associated pain). zovirax oral presentations should be considered for the treatment of chickenpox in certain groups at increased risk of severe varicella or its complications. these groups are as follows: 1. non-pregnant patients over 13 years-of-age who are otherwise healthy. 2. children over 12 months of age with a chronic cutaneous or pulmonary condition, or receiving long-term salicylate therapy. 3. children receiving sho

Ισραήλ - Εβραϊκά - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - אבקה להכנת תמיסה לאינפוזיה - aciclovir 250 mg/vial - aciclovir - aciclovir - for the treatment of herpes simplex infections and severe initial genital herpes in the non immunocompromised. for the prophylaxis of herpes simplex infections in immune-compromised patients. in the treatment of varicella zoster infections. for herpes simplex encephalitis. for the treatment of herpes simplex infection in the neonate and infant up to 3 months of age.